Physician profile
Laura Mcdavid
NPI 1598346603
$1,838.88
in general payments reported to CMS, 2019-2025
11 companies · $564 in 2025
The $564 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.97 · 2022: $239 · 2023: $578 · 2024: $391 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $521.02 | 2022-2025 | |
| Stryker Corporation | $318.92 | 2023-2025 | Scopis Ent |
| Medtronic, INC. | $236.85 | 2022-2025 | Stealthstation S8 Platform |
| Regeneron Healthcare Solutions, INC. | $170.75 | 2021-2023 | Dupixent |
| Optinose US, INC. | $142.06 | 2025 | |
| Phathom Pharmaceuticals, INC. | $124.74 | 2024 | Voquezna |
| Integra Lifesciences Corporation | $117.38 | 2021-2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Inspire Medical Systems, INC. | $101.66 | 2024-2025 | Inspire |
| Depuy Synthes Sales INC. | $49.70 | 2025 | Trumatch, Matrixmandible |
| Takeda Pharmaceuticals U.S.A., INC. | $35.83 | 2023 | Elaprase |
| Glaxosmithkline, LLC. | $19.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mcdavid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.